Not recruiting
Philadelphia positive chronic myeloid leukaemia
Not recruitingStudy on the Bioavailability of Nilotinib in Healthy Individuals with Chronic Myelogenous Leukemia (CML)
Registered drugNo placebo
Study on the Bioavailability of Nilotinib in Healthy Individuals with Chronic Myelogenous Leukemia (CML)
Registered drugNo placebo
- Disease:Philadelphia positive chronic myeloid leukaemia
- Substances:Nilotinib hydrochloride monohydrate
Countries:
Portugal
Portugal- Participants:18–64 years · Healthy volunteers
- Substances:Nilotinib hydrochloride monohydrate
- Sponsor:Bluepharma Industria Farmaceutica S.A.




